High-Throughput Screen for Inhibitors of


Journal

ACS omega
ISSN: 2470-1343
Titre abrégé: ACS Omega
Pays: United States
ID NLM: 101691658

Informations de publication

Date de publication:
15 Feb 2022
Historique:
received: 23 11 2021
accepted: 08 12 2021
entrez: 21 2 2022
pubmed: 22 2 2022
medline: 22 2 2022
Statut: epublish

Résumé

The continuing emergence of antibacterial resistance reduces the effectiveness of antibiotics and drives an ongoing search for effective replacements. Screening compound libraries for antibacterial activity in standard growth media has been extensively explored and may be showing diminishing returns. Inhibition of bacterial targets that are selectively important under in vivo (infection) conditions and, therefore, would be missed by conventional in vitro screens might be an alternative. Surrogate host models of infection, however, are often not suitable for high-throughput screens. Here, we adapted a medium-throughput

Identifiants

pubmed: 35187355
doi: 10.1021/acsomega.1c06633
pmc: PMC8851646
doi:

Types de publication

Journal Article

Langues

eng

Pagination

5401-5414

Informations de copyright

© 2022 The Authors. Published by American Chemical Society.

Déclaration de conflit d'intérêts

The authors declare the following competing financial interest(s): All authors were employed at Novartis at the time of their contributions to this work and would have received compensation in the form of salary and may have received Novartis stock.

Références

Cell Microbiol. 2006 Jan;8(1):139-48
pubmed: 16367873
Cell Microbiol. 2013 Aug;15(8):1313-22
pubmed: 23617769
mBio. 2012 Aug 31;3(4):
pubmed: 22911967
mBio. 2012 Oct 02;3(5):
pubmed: 23033474
Emerg Infect Dis. 2014 Nov;20(11):1812-20
pubmed: 25341126
Open Forum Infect Dis. 2014 Jun 02;1(1):ofu028
pubmed: 25734101
Proc Natl Acad Sci U S A. 2019 Sep 10;116(37):18597-18606
pubmed: 31439817
Nat Rev Microbiol. 2019 May;17(5):295-306
pubmed: 30837684
Trends Cell Biol. 2018 Feb;28(2):143-156
pubmed: 29173800
Future Microbiol. 2012 Jun;7(6):669-71
pubmed: 22702521
J Biomol Screen. 1999;4(2):67-73
pubmed: 10838414
Science. 2010 Feb 19;327(5968):1010-3
pubmed: 20167788
Bioorg Med Chem Lett. 2018 Feb 15;28(4):748-755
pubmed: 29336873
Infect Immun. 1994 Oct;62(10):4495-9
pubmed: 7927714
J Med Chem. 2018 Oct 25;61(20):9360-9370
pubmed: 30226381
PLoS One. 2012;7(12):e51732
pubmed: 23240059
Int J Antimicrob Agents. 2018 Aug;52(2):307-308
pubmed: 29898411
Antimicrob Agents Chemother. 1998 Feb;42(2):399-403
pubmed: 9527793
J Clin Microbiol. 2019 Oct 23;57(11):
pubmed: 31434721
J Clin Microbiol. 2011 Aug;49(8):3012-4
pubmed: 21677064
J Infect Dis. 1993 Sep;168(3):766-9
pubmed: 8354919
ACS Infect Dis. 2019 Jul 12;5(7):1045-1051
pubmed: 30861342
Proc Natl Acad Sci U S A. 2019 Sep 10;116(37):18655-18663
pubmed: 31455739
SLAS Discov. 2018 Jun;23(5):474-488
pubmed: 29370716
J Bacteriol. 2001 Jun;183(12):3564-73
pubmed: 11371519
Ann N Y Acad Sci. 2019 Jan;1435(1):18-38
pubmed: 29446459
Antimicrob Agents Chemother. 2019 Jun 24;63(7):
pubmed: 31036686
J Biomol Screen. 2007 Sep;12(6):855-64
pubmed: 17644773
Sci Rep. 2018 Mar 2;8(1):3939
pubmed: 29500372
JMM Case Rep. 2018 May 17;5(9):e005130
pubmed: 30425831
Antimicrob Agents Chemother. 2015 Sep;59(9):5511-9
pubmed: 26124156
Nat Biotechnol. 2002 May;20(5):478-83
pubmed: 11981561
Front Cell Infect Microbiol. 2017 Nov 21;7:483
pubmed: 29209595
mBio. 2018 Nov 20;9(6):
pubmed: 30459193
Antimicrob Agents Chemother. 2011 Jun;55(6):3022-4
pubmed: 21402838
Emerg Infect Dis. 2010 Sep;16(9):1490-1
pubmed: 20735943
Expert Rev Anti Infect Ther. 2019 Feb;17(2):71-73
pubmed: 30501374
Front Microbiol. 2020 Feb 21;11:266
pubmed: 32153546
Front Cell Infect Microbiol. 2019 Nov 08;9:367
pubmed: 31781512
Expert Rev Anti Infect Ther. 2018 Apr;16(4):259-268
pubmed: 29451043
Bioorg Med Chem. 2000 Apr;8(4):833-9
pubmed: 10819172
Antimicrob Agents Chemother. 2010 Dec;54(12):4971-7
pubmed: 20855724
Antimicrob Agents Chemother. 2015 Nov 23;60(2):845-54
pubmed: 26596941
Nature. 2017 May 18;545(7654):299-304
pubmed: 28489819
Cold Spring Harb Perspect Med. 2016 Jul 01;6(7):
pubmed: 27235477
Cell Microbiol. 2007 May;9(5):1336-42
pubmed: 17474906
Infect Immun. 1989 Feb;57(2):546-52
pubmed: 2643575
PLoS One. 2013;8(2):e56847
pubmed: 23457627
J Bacteriol. 2006 Dec;188(23):8259-71
pubmed: 17012394
Genome Res. 2012 Dec;22(12):2541-51
pubmed: 22826510
Cureus. 2017 Jun 28;9(6):e1403
pubmed: 28852600
ACS Infect Dis. 2015 Jun 12;1(6):232-3
pubmed: 27622738
PLoS Pathog. 2021 Mar 15;17(3):e1009376
pubmed: 33720976
Annu Rev Biochem. 2002;71:635-700
pubmed: 12045108
Infect Immun. 2010 Sep;78(9):3993-4000
pubmed: 20643860
Antimicrob Agents Chemother. 2019 Jun 24;63(7):
pubmed: 30988151
Nat Med. 2020 May;26(5):705-711
pubmed: 32284589
Trends Microbiol. 2009 Oct;17(10):433-8
pubmed: 19765999
Infect Immun. 2013 Oct;81(10):3552-65
pubmed: 23836821
mBio. 2018 Aug 7;9(4):
pubmed: 30087173
Emerg Infect Dis. 2016 Sep;22(9):1687-8
pubmed: 27532217
J Bacteriol. 1992 Jul;174(14):4614-21
pubmed: 1378055
J Med Chem. 2017 Jun 22;60(12):5002-5014
pubmed: 28549219
Methods Mol Biol. 2014;1149:681-8
pubmed: 24818942
Antimicrob Agents Chemother. 2019 Oct 22;63(11):
pubmed: 31451507
Lancet Infect Dis. 2018 Jan;18(1):37-46
pubmed: 28864030
Antimicrob Agents Chemother. 2016 Jul 22;60(8):5076-9
pubmed: 27270288
JAMA. 2016 Sep 20;316(11):1193-1204
pubmed: 27654605
Microorganisms. 2020 Jul 22;8(8):
pubmed: 32707871
Antimicrob Agents Chemother. 2014;58(1):518-26
pubmed: 24189257
Curr Opin Infect Dis. 2018 Aug;31(4):341-346
pubmed: 29847328
Infect Immun. 1989 Dec;57(12):3778-82
pubmed: 2680983
J Med Chem. 2008 May 22;51(10):2871-8
pubmed: 18260614
Cell Microbiol. 2008 Mar;10(3):729-40
pubmed: 18042255
Res Microbiol. 2019 Apr - May;170(3):156-164
pubmed: 30716390
PLoS One. 2012;7(11):e48922
pubmed: 23145022
Int J Antimicrob Agents. 2008 Dec;32 Suppl 4:S215-22
pubmed: 19134522
Trans R Soc Trop Med Hyg. 2008 Dec;102 Suppl 1:S152-62
pubmed: 19121678
Clin Infect Dis. 2014 Jan;58(2):225-32
pubmed: 24099919
J Biol Chem. 2010 Jun 18;285(25):19668-87
pubmed: 20410291
Expert Opin Investig Drugs. 2002 Aug;11(8):1149-59
pubmed: 12150708
J Infect Dis. 2009 Feb 15;199(4):513-21
pubmed: 19143563
J Antimicrob Chemother. 2018 Dec 1;73(12):3317-3321
pubmed: 30239821
Virulence. 2013 Feb 15;4(2):107-18
pubmed: 23302790
J Med Chem. 2014 Dec 11;57(23):10144-61
pubmed: 25402200
Cell Microbiol. 2005 Mar;7(3):307-14
pubmed: 15679834

Auteurs

Angela L Woods (AL)

Infectious Diseases, Novartis Institutes for Biomedical Research Inc, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States.

David Parker (D)

Global Discovery Chemistry, Novartis Institutes for Biomedical Research Inc, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States.

Meir M Glick (MM)

Chemical Biology and Therapeutics, Novartis Institutes for Biomedical Research Inc, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States.

Yunshan Peng (Y)

Global Discovery Chemistry, Novartis Institutes for Biomedical Research Inc, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States.

Francois Lenoir (F)

Global Discovery Chemistry, Novartis Institutes for Biomedical Research Inc, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States.

Evan Mulligan (E)

Chemical Biology and Therapeutics, Novartis Institutes for Biomedical Research Inc, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States.

Vincent Yu (V)

Chemical Biology and Therapeutics, Novartis Institutes for Biomedical Research Inc, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States.

Grazia Piizzi (G)

Global Discovery Chemistry, Novartis Institutes for Biomedical Research Inc, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States.

Troy Lister (T)

Global Discovery Chemistry, Novartis Institutes for Biomedical Research Inc, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States.

Maria-Dawn Lilly (MD)

Infectious Diseases, Novartis Institutes for Biomedical Research Inc, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States.

JoAnn Dzink-Fox (J)

Infectious Diseases, Novartis Institutes for Biomedical Research Inc, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States.

Johanna M Jansen (JM)

Global Discovery Chemistry, Novartis Institutes for Biomedical Research Inc, Emeryville California 94608-2916, United States.

Neil S Ryder (NS)

Infectious Diseases, Novartis Institutes for Biomedical Research Inc, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States.

Charles R Dean (CR)

Infectious Diseases, Novartis Institutes for Biomedical Research Inc, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States.

Thomas M Smith (TM)

Chemical Biology and Therapeutics, Novartis Institutes for Biomedical Research Inc, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States.

Classifications MeSH